Manufacturing
🇪🇺 EMAEMA news and analysis for pharmaceutical BD, investment, and market access
Global pharma manufacturing insights: Track supply chain, CMC, regulatory compliance, and innovation trends impacting drug production. Stay ahead.
Showing 1–12 of 13 articles
Quick answer
NovaPharmaNews Manufacturing hub for EMA covers 13 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Navigating the Future of GMP: Reliance, Annex 1, and AI
EMA · 8 min
Dr. Elena RossiISCT 2026: EU Manufacturing Innovations Day 1
manufacturing · 8 min
Dr. Elena RossiNovelty Nobility Expands AGC Biologics Partnership for Bispecific Antibody Manufacturing
2 min
Sofia AlvarezPharmaceutical Manufacturing Software Market to Reach $7.87 Billion by 2030, Driven by 15.8% CAGR Growth
2 min
Prof. Marcus WebbSmall Molecule API Market Projected to Reach $202.53 Billion by 2036 as Generic Drug Demand Surges
2 min
Prof. Marcus WebbPharma News: Purdue Sentencing, Supply Chain Woes, ASCO Previews
general · 4 min
Dr. Elena RossiISCT 2026: Cell & Gene Therapy Manufacturing Innovations in Dublin
manufacturing · 4 min
Dr. Elena RossiSwiss Biotech Day 2026: Previewing Key Biotech Trends
biotech · 3 min
Dr. Elena RossiPharmaceutical Isolators Market Reaches $7.82 Billion as EU GMP Annex 1 Drives Manufacturing Safety Requirements
2 min
Prof. Marcus WebbMabwell Achieves First PIC/S GMP Compliance Certification from Jordan FDA for Biopharmaceutical Manufacturing
2 min
Prof. Marcus WebbContinuous Manufacturing in Pharmaceuticals: EU Regulatory Insights & Innovation
EMA · 12 min
Dr. Elena RossiCMO/CDMO Market to Reach $5.46 Billion by 2035 as Biologics Manufacturing Outsourcing Accelerates
2 min
Prof. Marcus WebbFrequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.
Explore intelligence